Trxade Group Inc. MEDS Archives - Page 2 of 9

WednesdayNov 18, 2020 1:53 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) to Host Virtual Presentation at Diamond Equity Research Emerging Growth Invitational

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that management will present at the Diamond Equity Research Emerging Growth Invitational. According to the update, the investor conference is scheduled to take place virtually on Dec. 1, 2020. Trxade Group CEO Suren Ajjarapu will, beginning at 3:40 p.m. Eastern Time on the day of the conference, host a virtual presentation to investors followed by a guided question and answer session. Interested parties may visit https://ibn.fm/OWrjU to register for the webinar and access a live audio webcast and a 90-day archived replay of the conference…

WednesdayNov 11, 2020 9:19 am

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Plans to Present at Virtual Fall Investor Summit

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that management will present at the Virtual Fall Investor Summit, hosted by Investor Summit Group and taking place November 16-18, 2020. According to the update, Trxade CEO Suren Ajjarapu is scheduled to participate in one-on-one meetings throughout the event and will host a virtual presentation at 2:30 p.m. Eastern Time (11:30 p.m. Pacific Time) on Tuesday, November 17, 2020. Interested parties may visit https://ibn.fm/gf2UL to register for the event and access the live webcast and archive of the presentation. To view the full press release, visit…

WednesdayOct 28, 2020 10:22 am

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Releases Q3 2020 Financials, Marks Record Numbers

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, has released financial numbers for its third quarter. Financial highlights include third-quarter revenues up by 174% to $6.3 million, compared to revenue of $2.3 million in the same quarter last year; third-quarter gross profit increased 47% to $1.9 million, compared to gross profit of $1.3 million in the same quarter last year; and third-quarter net income reached $0.14 million compared to net income in the same quarter last year. Business highlights for the quarter included the addition of 144 new independent pharmacies; the unveiling of Bonum+, a B2B platform that…

TuesdayOct 27, 2020 9:42 am

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) to Announce Q3 2020 Results, Host Conference Call

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health-care platform, will release financial results for the third quarter ended September 30, 2020, after market close on Monday, October 26, 2020. According to the update, Trxade management will host a conference call to discuss the results at 5:00 p.m. Eastern Time on Monday, October 26, 2020. The call will conclude with Q&A from participants. Interested parties may join the call by dialing 1-877-425-9470 (U.S.) or 1-201-389-0878 (International) and entering conference ID: 13711397. To register for the event, visit the following webcast link: https://ibn.fm/E4I4K. Attendees are asked to dial in…

WednesdayOct 21, 2020 1:45 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Shines Digital Spotlight on Telehealth Services, Smart Technology

Trxade Group NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, was showcased at several recent virtual conferences and events. In a realm not limited by location, the company’s leadership took advantage of the opportunity to boost exposure of Trxade’s innovative platform and solutions to potential investors. Among capabilities highlighted in the digital spotlight, Trxade’s business-to-consumer (“B2C”) services took center stage in relevance for today’s environment, where the most critical needs are met with a next-generation response. An article discussing this reads, “The company’s B2C operations are led via Bonum Health, which provides 24/7 access to Board-Certified Providers and Health…

TuesdayOct 13, 2020 2:06 pm

QualityStocksNewsBreaks – Trxade Group Inc.’s (NASDAQ: MEDS) Bonum Health Partners with SingleCare to Enhance Enterprise Telehealth Solutions

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health-care platform, today announced that its Bonum Health subsidiary has partnered with SingleCare, the prescription savings service. According to the update, the collaboration is designed to enhance Bonum’s enterprise telehealth solutions with prescription discounts powered by SingleCare. The enterprise service will be offered to national, regional and local pharmacies to promote the benefit to underserved communities and uninsured patients. “The Bonum Health and SingleCare teams understand the importance of integrating and sustaining an affordable health-care solution at pharmacy point-of-care,” Bonum Health President Ashton Maaraba said in the news release. “We…

ThursdayOct 08, 2020 3:26 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Offers Real-Time Access to Pharmaceuticals to Increase Competition, Reduce Costs

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, assists pharmacies in cutting costs in an era where the pricing of medication poses a major challenge that significantly inflates health-care spending. Trxade’s pharmaceutical trading platform is designed to reduce costs, assisting smaller pharmacies to compete through providing radical price transparency and increased market competition. A recent article discussing this reads, “The online marketplace hosted by the Trxade Group offers pharmacies a real opportunity to reduce purchase costs. Called the Trxade Exchange, the platform gives small pharmacies access to the wider pharmaceutical distribution network, allowing them to search for and…

MondayOct 05, 2020 12:27 pm

Revenue Growth Amid Pandemic Helps Trxade Group, Inc. (NASDAQ: MEDS) Build its Transparency in Pharmaceuticals Strategy

Pharmaceutical services innovator Trxade Group Inc. has gained investor attention as it has emerged as a responsive healthcare market force during the ongoing COVID-19 pandemic As the pandemic began to unfold earlier this year, Trxade Group saw revenues jump effectively to three times their previous Q1 level, largely as a result of personal protective equipment products The company’s core mission has been to help small, community-centered retail pharmacies compete with large national chains through prescription drug price transparency and AI-driven protocols that help pharmacies stay abreast of what’s available Trxade Group’s advances in delivering services ranging from consultation to drug…

FridayOct 02, 2020 2:27 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) CEO Discusses Strategic Business Models, Nascent Stage of B2C Platform

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, showcased its powerful capabilities during a recent virtual investor summit. Trxade Group’s CEO Suren Ajjarapu presented for the company to discuss the platform, which thrives on its business-to-business (“B2B”) model to provide radical transparency for drug pricing and availability while taking advantage of telehealth-friendly insurer policy shifts under its business-to-consumer (“B2C”) model. During his presentation, Ajjarapu highlighted comprehensive capabilities of the platform, including the vitality of its Bonum Health Hub portal-led B2C operations, serving approximately 15 million patients through the medium of over 11,700 independent pharmacies in its subscription…

ThursdayOct 01, 2020 3:16 pm

Trxade Group, Inc. (NASDAQ: MEDS) Ending Q3 Strong with Increased Investor Exposure

The company’s current independent pharmacy member base represents over 50% of the United States pharmaceutical market within that vertical Actively used in all 50 states with over 11,700 pharmacies in its network, serving around 15 million patients indirectly through these networks of pharmacies Pharmaceutical supplies and services provider Trxade Group (NASDAQ: MEDS) benefited from an increased exposure to potential investors in September, by attending several virtual investor events and conferences, where it was given the opportunity to present its innovative platform and its advantages for pharmacy members. The company started the last month of the third fiscal quarter strong by…

Site Search

Company Search

Tag: Trxade Group Inc. MEDS